Patent Assignment
Reel/Frame 039980/0922
Change of Name
Recorded: 2016-09-09
Pages: 6
Assignor
MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Executed: 2007-01-16
Assignee
PROSPECT PHARMACEUTICALS, INC.
MARLBOROUGH STREET, BOSTON, MASSACHUSETTS, 02116
Covered Properties
(2)
Composition and Uses of Galectin Antagonist
Application:
14/574,853 →
Publication:
US 2015/0133399
Composition and Uses of Galectin Antagonists
Application:
15/055,103 →
Publication:
US 2016/0346317
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 26, 2016
From: GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT INC.
Reel/Frame 039556/0518 →
Assignment of Assignor's Interest
Aug 26, 2016
From: CHANG, YAN; SASAK, VODEK
To: GLYCOGENESYS, INC.
Reel/Frame 039849/0674 →
Change of Name
Sep 9, 2016
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 039980/0936 →
Assignment of Assignor's Interest
Sep 9, 2016
From: PROSPECT THERAPEUTICS, INC.
To: TANG CAPITAL PARTNERS LP
Reel/Frame 039981/0127 →
Assignment of Assignor's Interest
Oct 12, 2016
From: TANG CAPITAL PARTNERS LP
To: SOLANA THERAPEUTICS, INC.
Reel/Frame 039997/0227 →
Assignment of Assignor's Interest
Oct 12, 2016
From: SOLANA THERAPEUTICS, INC.
To: LA JOLLA PHARMACEUTICAL COMPANY
Reel/Frame 039997/0262 →
Merger
Oct 12, 2016
From: LA JOLLA PHARMACEUTICAL COMPANY
To: LJPC MERGER SUB, INC.
Reel/Frame 039998/0275 →
Merger and Change of Name
Oct 12, 2016
From: LJPC MERGER SUB, INC.; LA JOLLA PHARMACEUTICAL COMPANY
To: LA JOLLA PHARMCEUTICAL COMPANY
Reel/Frame 039998/0504 →